I just saw this in the NY Times: https://www.ny
Post# of 1460
https://www.nytimes.com/2020/02/10/health/alz...-drug.html
I agree Drano....it sure seems like the approach AVXL is taking should be getting some attention since every drug that tries via amyloid plaque seems to fail. I keep thinking that I need to acquire more shares before the PDD results become known in mid 2020 and its already mid-February.
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)